Article
Cancer-associated loss-of-function mutations implicate DAPK3 as a tumor-suppressing kinase.
Cancer research - 15 Apr 2011
Brognard John, Zhang You-Wei, Puto Lorena A, Hunter Tony
Abstract excerpt
Cancer kinome sequencing studies have identified several protein kinases predicted to possess driver (i.e., causal) mutations. Using bioinformatic applications, we have pinpointed DAPK3 (ZIPK) as a novel cancer-associated kinase with functional mutations. Evaluation of nonsynonymous point mutations, discovered in DAPK3 in various tumors (T112M, D161N, and P216S), reveals that all three mutations decrease or...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
